RR

Ritika Ramnani

Active Director Director DIN 11200962
DIN 11200962 First appointment Sep 2025 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value •••• Premium profile

About Ritika Ramnani

Data last updated:

Ritika Ramnani is a Director at Egis Healthcare Services Private Limited (since 2025). The company operates in Healthcare. Egis Healthcare Services Private Limited reported revenue of ₹6,081 (FY 2025).

DIN 11200962
Primary Designation Director
Industry Healthcare
First Appointment 10 Sep 2025
Largest company Egis Healthcare Services Private Limited · ₹6,081 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Sep 2025₹6,081 (FY 2025)Active

Board colleagues of Ritika Ramnani

Directorship timeline

Open interactive timeline →
Egis Healthcare Services Private Limited
Premium access

Shareholding and investment profile for Ritika Ramnani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ritika Ramnani

Ritika Ramnani currently holds 1 directorship: Egis Healthcare Services Private Limited (Director, since 10 Sep 2025, revenue ₹6,081 (FY 2025)).

Ritika Ramnani was first appointed on 10 Sep 2025 as Director at Egis Healthcare Services Private Limited.

The current boards of Ritika Ramnani's companies include Rajesh Bhojwani (Egis Healthcare Services Private Limited), Sanjana Bhojwani (Egis Healthcare Services Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available